business

Kiran Mazumdar-Shaw Aims to Enhance Access to Essential Medications

21 Ağustos 2026Bloomberg

Kiran Mazumdar-Shaw, known as India's 'Queen of Biotech', has transformed Biocon from a small garage operation into a multibillion-dollar enterprise, becoming a major player in insulin production and biosimilars. As she prepares to pass on her legacy, she reflects on her journey as a pioneering female entrepreneur a…
In an interview with Bloomberg, she shares insights on the future of healthcare and the role of AI in India.
Kiran Mazumdar-Shaw founded Biocon in 1978, and over the decades, the company has grown to become a leader in biotechnology, particularly in the production of insulin and biosimilars. Her leadership has not only shaped the company but has also influenced the broader biotech landscape in India.
Mazumdar-Shaw's journey exemplifies the potential of female entrepreneurship in traditionally male-dominated industries. Her focus on expanding access to vital drugs highlights a crucial intersection of business and social responsibility, particularly in a country like India where healthcare disparities persist.

NewsAI özeti

This article is for informational purposes only and does not constitute financial or investment advice.